• Bright Minds Biosciences granted stock options to directors, officers, consultants covering 109,000 common shares under its share option plan.
• Options carry an exercise price of US$ 83.4 per share, exercisable for five years from the grant date.
• Vesting is in four equal annual instalments of 25%, starting on the first anniversary of the grant date.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bright Minds Biosciences Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202605261918PRIMZONEFULLFEED9727015) on May 26, 2026, and is solely responsible for the information contained therein.